Sphingosine-1-phosphate: A potential therapeutic agent against human breast cancer

Investigational New Drugs

Volumn 29, Issue 2, 2011, Pages 396-399

  Ling, Binbing ^a   Chen, Lifeng ^a   Alcorn, Jane ^a   Ma, Baohua ^b   Yang, Jian ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b Nanhai Entry Exit Inspection and Quarantine Bureau   (China)

Author keywords

Apoptosis; Breast cancer; Cytotoxicity; Drug combination therapy; Proliferation

Indexed keywords

CYTOTOX 96; DOCETAXEL; LYASE; MESSENGER RNA; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE LYASE; SPHINGOSINE KINASE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; LYSOPHOSPHOLIPID; PHOSPHOTRANSFERASE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE LYASE (ALDOLASE); SPHINGOSINE 1-PHOSPHATE; SPHINGOSINE 1-PHOSPHATE LYASE (ALDOLASE); TAXOID;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER STAGING; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG POTENCY; DRUG POTENTIATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAMMARY GLAND; PRIORITY JOURNAL; UPREGULATION; BREAST TUMOR; CELL PROLIFERATION; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY;

ALDEHYDE-LYASES; APOPTOSIS; BREAST NEOPLASMS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYSOPHOSPHOLIPIDS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RNA, MESSENGER; SPHINGOSINE; TAXOIDS;

EID: 79957528099     PISSN: 01676997     EISSN: 15730646     Source Type: Journal    
DOI: 10.1007/s10637-009-9375-9     Document Type: Article

References (26)

1. Ogretmen B (2006) Sphingolipids in cancer: regulation of pathogenesis and therapy. FEBS Lett 580:5467-5476 (Pubitemid 44465911)
2. Olivera A, Spiegel S (1993) Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 365:557-560 (Pubitemid 23317779)
3. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind S, Spiegel S (1996) Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381:800-803 (Pubitemid 26243122)
4. Hung WC, Chuang LY (1996) Induction of apoptosis by sphingosine-1- phosphate in human hepatoma cells is associated with enhanced expression of bax gene product. Biochem Biophys Res Commun 229:11-15
5. Katsuma S, Hada Y, Ueda T, Shiojima S, Hirasawa A, Tanoue A, Takagaki K, Ohgi T, Yano J, Tsujimoto G (2002) Signalling mechanisms in sphingosine 1-phosphate-promoted mesangial cell proliferation. Genes Cells 7:1217-1230 (Pubitemid 36024598)
6. Spiegel S, Milstien S (2000) Sphingosine-1-phosphate: signaling inside and out. FEBS Lett 476:55-57 (Pubitemid 30394650)
7. Oskouian B, Mendel J, Shocron E, Lee MA Jr, Fyrst H, Saba JD (2005) Regulation of sphingosine-1-phosphate lyase gene expression by members of the GATA family of transcription factors. J Biol Chem 280:18403-18410 (Pubitemid 41389089)
8. Johnson KR, Johnson KP, Becker KP, Bielawski J, Mao C, Obeid LM (2003) Role of human sphingosine-1-phosphate phosphatase 1 in the regulation of intra- and extracellular sphingosine-1- phosphate levels and cell viability. J Biol Chem 278:34541-34547 (Pubitemid 37553303)
9. Lee MJ, Thangada S, Claffey KP, Ancellin N, Liu CH, Kluk M, Volpi M, Sha'afi RI, Hla T (1999) Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99:301-312 (Pubitemid 29519909)
10. Wang W, Huang MC, Goetzl EJ (2007) Type 1 sphingosine 1- phosphate G protein-coupled receptor (S1P1) mediation of enhanced IL-4 generation by CD4 T cells from S1P1 transgenic mice. J Immunol 178:4885-4890 (Pubitemid 46595270)
11. Maceyka M, Payne SG, Milstien S, Spiegel S (2002) Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta 1585:193-201 (Pubitemid 36096858)
12. Ikeda M, Kihara A, Igarashi Y (2004) Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5'-phosphate binding domain exposed to the cytosol. Biochem Biophys Res Commun 325:338-343 (Pubitemid 39441198)
13. Long J, Darroch P, Wan KF, Kong KC, Ktistakis N, Pyne NJ, Pyne S (2005) Regulation of cell survival by lipid phosphate phosphatases involves the modulation of intracellular phosphatidic acid and sphingosine 1-phosphate pools. Biochem J 391:25-32 (Pubitemid 41445472)
14. Mendel J, Heinecke K, Fyrst H, Saba JD (2003) Sphingosine phosphate lyase expression is essential for normal development in Caenorhabditis elegans. J Biol Chem 278:22341-22349 (Pubitemid 36830283)
15. Oskouian B, Sooriyakumaran P, Borowsky AD, Crans A, Dillard- Telm L, Tam YY, Bandhuvula P, Saba JD (2006) Sphingosine-1- phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer. Proc Natl Acad Sci USA 103:17384-17389 (Pubitemid 44788978)
16. Reiss U, Oskouian B, Zhou J, Gupta V, Sooriyakumaran P, Kelly S, Wang E, Merrill AH Jr, Saba JD (2004) Sphingosine-phosphate lyase enhances stress-induced ceramide generation and apoptosis. J Biol Chem 279:1281-1290 (Pubitemid 38082652)
17. Olivera A, Kohama T, Edsall L, Nava V, Cuvillier O, Poulton S, Spiegel S (1999) Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J Cell Biol 147:545-558
18. Dowsett M, Archer C, Assersohn L, Gregory RK, Ellis PA, Salter J, Chang J, Mainwaring P, Boeddinghaus I, Johnston SR, Powles TJ, Smith IE (1999) Clinical studies of apoptosis and proliferation in breast cancer. Endocr Relat Cancer 6:25-28 (Pubitemid 29197224)
19. Parton M, Dowsett M, Smith I (2001) Studies of apoptosis in breast cancer. BMJ 322:1528-1532 (Pubitemid 32588351)
20. Nakagawa H, Nihonmatsu N, Ohta S, Hirobe M (1996) Effects of new endogenous nonprotein amino acids, 1, 2, 3, 4- tetrahydroisoquinoline-3- carboxylic acid derivatives, on behavior of mice. Biochem Biophys Res Commun 225:1027-1034 (Pubitemid 26319221)
21. Robinson ES, Anderson NJ, Crosby J, Nutt DJ, Hudson AL (2003) Endogenous beta-carbolines as clonidine-displacing substances. Ann N Y Acad Sci 1009:157-166
22. Nakagawa H, Yamada M, Maeda N, Iwatsuki K, Hirayama A, Ikenaka K (1999) Clinical trial of intrathecal administration of 5- fluoro-2'-deoxyuridine for treatment of meningeal dissemination of malignant tumors. J Neurooncol 45:175-183 (Pubitemid 30197731)
23. Okajima F (2002) Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator? Biochim Biophys Acta 1582:132-137 (Pubitemid 34634121)
24. Olsen SR (2005) Taxanes and COX-2 inhibitors: from molecular pathways to clinical practice. Biomed Pharmacother 59(Suppl 2): S306-S310
25. Piccart MJ, Biganzoli L, Di Leo A (2000) The impact of chemotherapy dose density and dose intensity on breast cancer outcome: what have we learned? Eur J Cancer 36(Suppl 1):S4-S10
26. St Louis EK (2009) Truly "rational" polytherapy: maximizing efficacy and minimizing drug interactions, drug load, and adverse effects. Curr Neuropharmacol 7:96-105